Newborn Screening Working Group (NBS-WG)

Newborn screening is the process of systematically testing newborns just after birth for certain treatable diseases. Ideally, this practice is part of a larger programme that includes confirmatory diagnosis, immediate care, treatment and follow-up. The EURORDIS Newborn Screening Working Group (NBS-WG) was set up to review current policy and practice in the field of NBS, in order to develop principles for harmonious uptake/adoption of the NBS programs across the Member States with a view to delivering maximum benefit and improving outcomes for babies born with rare diseases.

Members of NBS-WG include representatives from patient organizations, international screening societies and international and national federations with a focus on NBS.

In January 2021, EURORDIS, alongside its Council of National Alliances, Council of European Federations and its members, have set out 11 Key Principles to support an harmonised European approach to Newborn Screening.

Name Organization Country
Anna Kole EURORDIS  France
Clara Hervas EURORDIS  Belgium
Cor Oosterwijk VSOP The Netherlands
Domenica Taruscio Istituto Superiore di Sanità Italy
Eduardo Lopez  Spanish association for lysosomal acid lipase deficiency (AELALD) Spain 
Francesca Forzano  European Society of Human Genetics (ESHG) United Kingdom
Gulcin Gumus EURORDIS  Spain 
Jayne Spink Genetic Alliance UK United Kingdom
Johan Prevot (observer) IPOPI Portugal
Johanna Pfeil The European Foundation for the Care of Newborn Infants (EFCNI) Germany
Laetitia Ouillade SMA Europe France
Luc Zimmermann The European Foundation for the Care of Newborn Infants (EFCNI) Germany
Manuela Vaccarotto Associazione Italiana Sostegno Malattie Metaboliche Ereditarie (AISMME) Italy
Mark Turner University of Liverpool United Kingdom
Martina Cornel Amsterdam UMC The Netherlands
Patricia Arias FEDER Spain 
Simona Bellagambi UNIAMO Italy
Valentina Bottarelli EURORDIS  Belgium
Virginie Bros-Facer EURORDIS  France

 

Page created: 15/06/2020
Page last updated: 03/06/2021
 
 
La voz de los pacientes de enfermedades raras en EuropaEURORDIS La voz internacional de las personas que tienen enfermedades rarasRare Disease International Reuniendo a pacientes, familiares y expertos para compartir experiencias en un foro moderado en distintos idiomas. RareConnect El Programa Rare Barometer es una iniciativa de EURORDIS que realiza encuestas para transformar las experiencias de los pacientes con enfermedades raras en cifras que puedan compartirse con los responsables políticos.Rare Barometer Una campaña internacional de sensibilización que se celebra todos los años el último día de febrero, El Día de las Enfermedades Raras es una iniciativa de EURORDISRare Disease Day Únete al mayor grupo de partes interesadas en toda Europa, en la Conferencia Europea sobre Enfermedades Raras y Medicamentos Huérfanos que se celebra cada dos años. ECRD es una iniciativa de EURORDISEuropean Conference on Rare Diseases